About Us

Although the Program in BioMolecular Research is one of the smallest department/section in the Research Center, it gained both national and international recognition. The program focuses on a medically important family of genes that code for what are called AU-rich messenger RNAs (mRNAs). These code for many proteins that are critical in maintaining healthy transient reactions during the body responses such as immune response and cellular growth. Disturbances in these transient processes may lead to unwanted prolonged responses and thus diseases, such as chronic inflammation and cancer. Thus, the program implements laboratory studies of this area in different disease conditions and pinpoint pathways that can be targeted for therapy.

The research program employs the fields of functional genomics, functional proteomics, and molecular therapeutics to achieve its aim by narrowing the human transcriptome and proteome to early and transient response players. Using unique tools specific to the study of mRNA stability and/or translation that are developed solely by our program, our platform is internationally recognized as attested by the publications, collaborations, and grants.

Our funding comes from:

 King Faisal Specialist Hospital and Research Center

 King Abdulaziz City for Science and Technology

 National Institute of Health

 The Center for Excellence in Biotechnology, King Saud University

And we have active collaborations with:

 Cleveland Clinic, U.S.

 University of Washington, U.S.

 INSERM, France

 Istituto Nazionale Ricerca sul Cancro, Italy

 University of California, U.S.

 Vanderbilt University, U.S.

 Medical School Hanover, Germany

 Imperial College London, UK

Text Box: The Biomolecular Research Program

King Faisal Specialist Hospital & Research Center

King Faisal Specialist Hospital & Research Center